Presence of COVID-19 Compatible CT Abnormalities
Conditions
Keywords
COVID19, 18F FDG PET, lung infection, CT, seriological tests
Brief summary
CT signs that are evocative of lung COVID-19 infections have been extensively described, whereas 18F-FDG-PET signs have not. Our current study aimed to identify specific COVID-19 18F-FDG-PET signs in patients that were (i) suspected to have a lung infection based on 18F-FDG-PET/CT recorded during the COVID-19 outbreak and (ii) whose COVID-19 diagnosis was definitely established or excluded by appropriate viral testing.
Interventions
DIAGNOSTIC_TESTPET-CT of 18F-FDG
Whole-body 18F-FDG-PET/CT was performed on a digital hybrid system (Vereos, Philips®)
Sponsors
Central Hospital, Nancy, France
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* Patient coming to nuclear medicine for 18F-flurodesoxyglucose (FDG) positron emission tomography computed tomography (PET-CT) with suspicion of lung involvement * patient affiliated to a social security scheme or equivalent * adult patient having been informed of the study
Exclusion criteria
* patient with a negative covid 19 test
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Visual analysis of pulmonary lobes | 1 day | Visual analysis of the pulmonary lobes by calculating a extent score for each patient |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Measurement of metabolic activity | 1 day | Measurement of metabolic activity with SUV max of lung areas with CT abnormalities |
Countries
France
Outcome results
None listed